[EN] NUCLEAR RECEPTOR MODULATORS AND THEIR USE FOR THE TREATMENT AND PREVENTION OF CANCER<br/>[FR] MODULATEURS DE RÉCEPTEURS NUCLÉAIRES ET LEUR UTILISATION POUR LE TRAITEMENT ET LA PRÉVENTION D'UN CANCER
申请人:US HEALTH
公开号:WO2012174436A1
公开(公告)日:2012-12-20
Disclosed are compounds which are nuclear receptor modulators that can act as antagonists to the androgen receptor, for example, a compound of Formula I: wherein R1 to R5 and X1 to X5 are as described herein, as well as pharmaceutically acceptable salts, solvates, and stereoisomers thereof. Pharmaceutical compositions comprising such compounds, as well as methods of use, and treatment for cancers, including prostate cancers, other nuclear receptor mediated cancers, and other conditions, are also disclosed.
本文披露了一些化合物,它们是核受体调节剂,可以作为雄激素受体的拮抗剂,例如,公式I的化合物:其中R1至R5和X1至X5如本文所述,以及其药用盐、溶剂化合物和立体异构体。还披露了包括这些化合物的药物组合物,以及使用方法和治疗癌症,包括前列腺癌、其他核受体介导的癌症和其他疾病的方法。